### Job Title: Manager, Upstream MSAT Department: Administration Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD 1 with the…
### Job Title: Manager, Downstream MSAT Department: CMC Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD 1 with the…
### Job Title: Clinical Trial Manager Department: Clinical Operations Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade of PD 1 with…
### Job Title: Director, Clinical Operations EU & Partner Liaison Department: Clinical Operations Location: Oxford, UK About Summit: Ivonescimab, known as SMT112, is a novel, potential first in class investigational bispecific antibody combining the effects of immunotherapy via a blockade…